Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Clinical trial NCT00734305 · COMPLETED
Trial details
- NCT number
- NCT00734305
- Sponsor
- Merrimack Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2010-05-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.